US OptionsDetailed Quotes
ASRT250117P3000
- 1.95
- 0.000.00%
15min DelayClose Jan 3 16:00 ET
0.00High0.00Low
1.95Open1.95Pre Close0 Volume12 Open Interest3.00Strike Price0.00Turnover1343.05%IV-18.78%PremiumJan 17, 2025Expiry Date2.12Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.2243Delta0.1360Gamma0.33Leverage Ratio-0.0273Theta-0.0007Rho-0.07Eff Leverage0.0005Vega
Assertio Stock Discussion
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
Friday, 13th December at 8:00 am
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced yesterday results of a clinical trial investigating the utility of Rolvedon® (eflapegrastim-x...
Underated/Valued, overlooked, great buy!!!
This one is killin it....
No comment yet